Join to View Full Profile
1500 E Medical Center DrB1 floor Cancer Recp CAnn Arbor, MI 48109
Phone+1 734-647-8906
Dr. Buckanovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2004- University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
Weill Cornell MedicineClass of 1998
Certifications & Licensure
PA State Medical License 1999 - 2026
MI State Medical License 2006 - 2019
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Start of enrollment: 2010 Apr 14
- Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients Start of enrollment: 2011 Oct 01
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 May 08
- Join now to see all
Publications & Presentations
PubMed
- Cost-Effectiveness Analysis of Tumor Testing for BRCA Pathogenic Variants in Epithelial Ovarian Cancer.Sarah E Taylor, Phuong L Mai, Heidi Donovan, Sarah G Bell, Shannon K Rush
American Journal of Clinical Oncology. 2025-07-01 - 1 citationsAged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation.Geyon L Garcia, Taylor Orellana, Grace Gorecki, Leonard Frisbie, Roja Baruwal
Cancer Discovery. 2025-06-03 - Role of the NuRD complex and altered proteostasis in cancer cell quiescence.Qi Jiang, Michelle Ertel, Austin Arrigo, Sara Sannino, Jennifer L Goeckeler-Fried
Biorxiv. 2025-02-14
Journal Articles
- Leukemia Inhibitory Factor Functions in Parallel with Interleukin-6 to Promote Ovarian Cancer GrowthKaren McLean, Ronald J Buckanovich, Moshe Talpaz, Nature
Press Mentions
Pitt Study Makes New Insights into the Origins of Ovarian CancerMarch 14th, 2025
Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian CancerOctober 28th, 2019
Targeting Stem-like Cells Could Prevent Ovarian Cancer RecurrenceMarch 12th, 2019- Join now to see all
Grant Support
- Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targetsMAGEE-WOMEN'S RES INST AND FOUNDATION2023–2028
- Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targetsMAGEE-WOMEN'S RES INST AND FOUNDATION2023–2028
- HCC Ovarian Cancer SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
- Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targetsMAGEE-WOMEN'S RES INST AND FOUNDATION2023–2028
- HCC Ovarian Cancer SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
- HCC Ovarian Cancer SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2028
- Defining the impact of stromal aging on ovarian cancer initiationUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- ALDH Inhibition as Modulator of Tumor ImmunobiologyMAGEE-WOMEN'S RES INST AND FOUNDATION2020–2025
- Targeting Ovarian Tumor Associated Myeloid Cells With Nanoparticles TherapeuticsNational Cancer Institute2012
- Using Embryonic Stem Cells To Re-Create A Human Tumor Microenvironment To DevelopOffice Of The Director, National Institutes Of Health2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
